UK National Smoking Cessation Conference - UKNSCC
UKNSCC home page UKNSCC archive

< BACK

Nicotine safety and misconceptions
Karl Fagerström

Abstract
Cigarette smoking is a major cause of death and disease worldwide. Nicotine has been shown to be the agent in tobacco smoke that leads to addiction. However, the overwhelming majority of the health consequences of smoking are caused by other ingredients in tobacco smoke such as carbon monoxide, numerous carcinogens, and other toxins that have been identified. Medicinal nicotine is used to wean people from the nicotine normally obtained by smoking. Whereas cigarettes are designed to maximize the addictive potential of nicotine, current medicinal nicotine products are by far less addictive. Medicinal nicotine may produce some adverse pharmacological effects; however, these are generally not clinically significant.
The effects of nicotine from medicinal nicotine products are much lower compared to smoking, even among smokers with pre-existing tobacco-related disease. There are some long-term safety data on medicinal nicotine products; furthermore, snus, a form of smokeless tobacco that delivers higher levels of nicotine, has been shown to lower the risk of myocardial infarction and lung cancer compared to smoking among exclusive snus users. Available evidence suggests that nicotine, delivered without the other constituents of tobacco smoke, has minimal adverse heath consequences. We will discuss the health effects of nicotine from medicinal nicotine compared to those from cigarette smoking, with particular reference to cardiovascular effects, carcinogenicity and lung disease; also, how these products could be used to help more smokers quit smoking.

Karl Fagerström
The Smokers' Information Centre, Helsingborg, Sweden
karl.fagerstrom@swipnet.se

TOP